SCHEDULE: Intracoastal Capital Reports 0% Stake in Microbot Medical
Amendment to Beneficial Ownership Report
Intracoastal Capital LLC and its affiliates have reported a 0% beneficial ownership in Microbot Medical Inc. common stock, excluding a warrant exercisable in March 2026.
Summary
- Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (the "Reporting Persons") beneficially own 0 shares of Microbot Medical Inc. common stock as of September 30, 2025.
- This represents 0.0% of the class of securities.
- The reported ownership excludes 6,002,185 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal Capital LLC (the "Intracoastal Warrant").
- The Intracoastal Warrant is not exercisable until March 16, 2026.
- The Intracoastal Warrant contains a blocker provision, preventing exercise if it would result in beneficial ownership exceeding 9.99% of the Common Stock.
- Without the blocker provision and if currently exercisable, the Reporting Persons would be deemed to beneficially own 6,002,185 shares of Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing reporting a change in beneficial ownership to 0% for the reporting parties, with details on a future exercisable warrant. It does not contain information directly impacting company performance or sentiment.
Positives
- The filing clarifies the current beneficial ownership status of the Reporting Persons, indicating no immediate voting or dispositive power over common shares.
- The non-exercisability of the warrant until March 2026 means no immediate dilution from this specific warrant source.
Negatives
- The Reporting Persons currently hold no common stock, meaning they do not have direct voting power or dispositive power over common shares.
Risks
- The future exercisability of the Intracoastal Warrant for 6,002,185 shares in March 2026 could lead to future dilution if exercised.
- The blocker provision, while limiting immediate concentration, also means the full potential ownership from the warrant may not be realized if it exceeds the 9.99% threshold.
Future Outlook
The warrant held by Intracoastal Capital LLC for 6,002,185 shares of common stock will become exercisable on March 16, 2026, subject to a 9.99% beneficial ownership blocker provision.
Industry Context
This is a routine ownership disclosure filing and does not provide specific industry context or trends.
Stakeholder Impact
- Shareholders should be aware that Intracoastal Capital LLC and its affiliates currently hold no common stock, but possess a significant warrant position that could convert to 6,002,185 shares (subject to a blocker) in March 2026, potentially increasing the outstanding share count.
Next Steps
- The Intracoastal Warrant will become exercisable on March 16, 2026, allowing the Reporting Persons to potentially acquire common stock.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement, representing the 'as of' date for beneficial ownership. |
| 11/07/2025 | Date the Schedule 13G Amendment No. 3 was signed by the Reporting Persons. |
| 03/16/2026 | Date the Intracoastal Warrant becomes exercisable. |
Keywords
Microbot Medical Inc., MBOT, Schedule 13G, beneficial ownership, common stock, warrant, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.